Key result
National CVD spending grew ~6% annually from 1996 to 2008, driven primarily by prevention.
Observational
Between 1996 and 2008, U.S. cardiovascular disease spending grew slower than overall national health expenditures (5.7% vs. 6.8% annually), largely due to slower growth in acute treatment spending (4.8%) alongside rapid growth in spending to manage hypertension and hyperlipidemia for primary prevention (9.9%).
Answers are grounded in this paper and cite their sources.
Prevention drove faster CVD spending growth than treatment; extends historical trend data but leaves open contemporary value questions.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2011) conducted an observational in Cardiovascular disease (ICD-10 I00-I99) and hyperlipidemia (ICD-10 E75, E78). National healthcare spending on cardiovascular disease (treatment, prevention, and research) vs. Overall National Health Expenditure Accounts (NHEA) spending was evaluated on Compound annual growth rate of national spending on cardiovascular disease from 1996 to 2008. National spending on cardiovascular disease grew at a 5.7% compound annual rate from 1996 to 2008, driven by a 9.9% growth in prevention and 4.8% growth in treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: